NasdaqCM - Delayed Quote USD

Vincerx Pharma, Inc. (VINC)

0.0500
-0.0050
(-9.09%)
At close: May 13 at 3:55:37 PM EDT
All numbers in thousands
Download
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
8,005
18,217
59,286
117,676
Total Liabilities Net Minority Interest
5,281
6,995
11,618
17,355
Total Equity Gross Minority Interest
2,724
11,222
47,668
100,321
Total Capitalization
2,724
11,222
47,668
100,321
Common Stock Equity
2,724
11,222
47,668
100,321
Capital Lease Obligations
0
2,502
3,436
4,174
Net Tangible Assets
2,724
11,222
47,668
100,321
Working Capital
1,129
9,128
46,808
97,922
Invested Capital
2,724
11,222
47,668
100,321
Tangible Book Value
2,724
11,222
47,668
100,321
Total Debt
0
2,502
3,436
4,174
Share Issued
2,239.5800
1,070.3750
1,062.1440
1,052.8780
Ordinary Shares Number
2,239.5800
1,070.3750
1,062.1440
1,052.8780
Treasury Shares Number
--
0
--
--
12/31/2021 - 5/27/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

AEON AEON Biopharma, Inc.
0.5022
+2.07%
 
XCUR Exicure, Inc.
11.40
-3.88%
 
CELUW Celularity Inc.
0.0400
+4.99%
 
ELEV Elevation Oncology, Inc.
0.3490
-3.14%
 
SLXN Silexion Therapeutics Corp
0.9702
-2.88%
 
AARD Aardvark Therapeutics, Inc.
10.14
-7.57%
 
ABP Abpro Holdings, Inc.
0.2050
-2.29%
 
VTYX Ventyx Biosciences, Inc.
1.2000
-0.83%
 
ERNA Ernexa Therapeutics Inc.
0.2190
+4.29%
 
CELU Celularity Inc.
1.8700
+23.03%